Insider · CIK 0001644975

Congleton Jon

Reports to the SEC for 4 companies · RADNOR, PA

sec.gov

Transactions

Companies

Filings

CIK

0001644975

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−75K sh	$25.46	−$1.91M	528,621
2026-07-13	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−10.7K sh	$27.24	−$291K	603,621
2026-07-05	IMUXIMMUNIC, INC. · Stock OptionA Award	Director	AAward	+25.4K sh	—	—	25,370
2026-06-30	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−17K sh	$26.82	−$456K	614,321
2026-06-30	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−58K sh	$25.94	−$1.5M	631,321
2026-06-29	IMUXIMMUNIC, INC. · Stock OptionA Award	Director	AAward	+50.7K sh	—	—	50,740
2026-04-29	AVLNAvalyn Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	26,978
2026-04-13	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.7K sh	$26.83	−$422K	689,321
2026-03-31	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−453 sh	$27.05	−$12.3K	705,051
2026-03-31	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−19.4K sh	$25.50	−$494K	760,687
2026-03-31	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−55.2K sh	$26.54	−$1.46M	705,504
2026-02-19	MLYSMineralys Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+141K sh	—	—	780,051
2026-02-19	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director, Chief Executive Officer	AAward	+188K sh	—	—	187,900
2026-01-12	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,117 sh	$33.15	−$236K	639,151
2026-01-12	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,119 sh	$32.21	−$294K	646,268
2025-11-21	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−24.1K sh	—	—	0
2025-11-21	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+24.1K sh	$0.54	+$13K	655,387
2025-11-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,862 sh	$42.31	−$375K	809,637
2025-11-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,000 sh	$43.50	−$174K	805,637
2025-11-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−29.2K sh	$45.20	−$1.32M	776,430
2025-11-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−32.9K sh	$46.89	−$1.54M	631,305
2025-11-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−112K sh	$45.83	−$5.15M	664,155
2025-11-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−12.8K sh	$41.64	−$533K	818,499
2025-10-13	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−13.5K sh	$42.63	−$578K	832,857
2025-10-13	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,552 sh	$43.03	−$66.8K	831,305
2025-07-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.9K sh	$14.51	−$230K	846,405
2025-04-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.3K sh	$12.19	−$187K	862,289
2025-02-13	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director, Chief Executive Officer	AAward	+570K sh	—	—	570,000
2025-01-13	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−18.3K sh	$9.06	−$166K	877,608
2024-10-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.3K sh	$13.52	−$206K	895,941
2024-07-11	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.7K sh	$13.34	−$210K	911,212
2024-06-20	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−14.9K sh	$11.73	−$175K	926,958
2024-06-18	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−16.6K sh	$11.99	−$199K	941,898
2024-06-17	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−17.8K sh	$12.25	−$218K	958,505
2024-06-14	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−16.2K sh	$12.52	−$203K	976,271
2024-06-13	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−40K sh	$12.74	−$509K	992,500
2024-06-12	MLYSMineralys Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−16.6K sh	$12.77	−$212K	1,032,461
2024-02-13	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director, Chief Executive Officer	AAward	+425K sh	—	—	425,000
2023-11-22	MLYSMineralys Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,250 sh	$5.97	+$25.4K	1,049,068
2023-09-06	MLYSMineralys Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,250 sh	$12.08	+$27.2K	1,044,818
2023-08-17	MLYSMineralys Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,250 sh	$12.10	+$27.2K	1,042,568
2023-08-11	MLYSMineralys Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,000 sh	$12.89	+$25.8K	1,040,318
2023-03-17	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director, Chief Executive Officer	AAward	+99.8K sh	—	—	99,800
2023-02-09	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,046
2016-09-12	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2016-06-16	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$3.87	+$19.3K	20,000
2016-03-24	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$4.22	+$21.1K	15,000
2016-03-22	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$4.38	+$21.9K	10,000
2015-12-11	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$8.10	+$40.5K	5,000
2015-09-11	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+121K sh	—	—	121,100

Recent filings

Accepted (ET)
Oct 24
Congleton Jon0001933414-26-000121
SEC(opens sec.gov)
Jul 154
Congleton Jon0001933414-26-000100
SEC(opens sec.gov)
Jul 74
Congleton Jon0001193805-26-000928
SEC(opens sec.gov)
Jun 304
Congleton Jon0001933414-26-000096
SEC(opens sec.gov)
Jun 294
Congleton Jon0001193805-26-000892
SEC(opens sec.gov)
May 14
Congleton Jon0001193125-26-201875
SEC(opens sec.gov)
Apr 154
Congleton Jon0001933414-26-000075
SEC(opens sec.gov)
Apr 24
Congleton Jon0001644975-26-000004
SEC(opens sec.gov)
Feb 204
Congleton Jon0001933414-26-000045
SEC(opens sec.gov)
Jan 134
Congleton Jon0001644975-26-000002
SEC(opens sec.gov)
Nov 244
Congleton Jon0001644975-25-000006
SEC(opens sec.gov)
Nov 134
Congleton Jon0001933414-25-000151
SEC(opens sec.gov)

Companies

Address

150 N. RADNOR CHESTER ROAD SUITE F200

RADNOR, PA, 19087